Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > Why Healthcare Needs Coordinated Infrastructure, Not More Point Solutions
Cotiviti ties together providers and payers, including the top 25 US health plans, that collectively serve 300 million members in the Unite...
No comments:
Post a Comment